Premium
Cancer Therapy: Biomaterials for Abrogating Metastasis: Bridging the Gap between Basic and Translational Research (Adv. Healthcare Mater. 18/2016)
Author(s) -
Conde João,
Shomron Noam,
Artzi Natalie
Publication year - 2016
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201670102
Subject(s) - nanomedicine , bridging (networking) , metastasis , cancer , nanotechnology , cancer metastasis , cancer therapy , translational research , medicine , disease , materials science , computer science , pathology , computer network , nanoparticle
Nanomaterials can be used to probe, sense and treat metastasis while facilitating in depth understanding of disease associated mechanisms. Leveraging the potential of nanomedicine to combat cancer spread at each stage of the metastatic process while exploiting different administration routes may facilitate the development of new cancer therapeutic approaches and improve (pre)‐clinical outcomes. Natalie Artzi and co‐workers outline the current challenges in this research field on page 2312.